5 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 8.4% per year over the past 4 years.
Net income has grown faster than revenue (24.9% vs 8.4% per year).
Operating margin has contracted, at 18.5% in the latest year.
Free cash flow has declined 1.7% per year over the past 4 years.
Financial health
Total debt ($103M) exceeds cash ($24M); net debt is $79M.
Total debt has grown faster than revenue (29.2% vs 8.4% per year).
Total debt is 2.6× EBITDA.
Shareholder returns
Dividends have been paid for 5 consecutive years, consuming 6.4% of earnings and 5.7% of free cash flow.
The dividend has declined 37.6% per year over the past 4 years.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$192M
$27M
0.0%
18.5%
$30M
$103M
$24M
2024
$197M
$3M
0.0%
16.0%
$39M
$109M
$39M
2023
$185M
$3M
0.0%
15.5%
$27M
$116M
$89M
2022
$165M
-$969000
0.0%
-36.8%
-$9M
$122M
$79M
2021
$139M
$11M
0.0%
24.8%
$32M
$37M
$130359
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$45M
$2M
0.0%
7.0%
$4M
$102M
$5M
Dec '25
$46M
$2M
0.0%
14.7%
$6M
$103M
$24M
Sep '25
$48M
$8M
0.0%
17.2%
$14M
$105M
$28M
Jun '25
$49M
$3M
0.0%
22.0%
$5M
$106M
$20M
Mar '25
$49M
$14M
0.0%
19.8%
$5M
$108M
$42M
Dec '24
$50M
$4M
0.0%
5.6%
$11M
$109M
$39M
Sep '24
$51M
$11M
0.0%
23.7%
$14M
$111M
$38M
Jun '24
$49M
-$7M
0.0%
12.7%
$7M
$113M
$26M
Mar '24
$47M
-$4M
0.0%
22.3%
$7M
$114M
$79M
Dec '23
$46M
$8M
0.0%
12.1%
$7M
$116M
$89M
Sep '23
$46M
$8M
0.0%
16.7%
-$291000
$117M
$66M
Jun '23
$49M
-$5M
0.0%
15.6%
$7M
$119M
$68M
Mar '23
$45M
-$7M
0.0%
17.6%
$13M
$120M
—
Dec '22
$44M
$2M
0.0%
16.4%
$6M
$122M
$79M
Sep '22
$42M
$15000
0.0%
18.6%
$6M
$123M
—
Jun '22
$41M
-$3M
0.0%
-207.0%
-$29M
$125M
—
Mar '22
$37M
$1M
0.0%
26.3%
$7M
—
$67898
Dec '21
$38M
-$1M
0.0%
15.8%
$9M
$37M
$130359
Sep '21
$36M
$3M
0.0%
25.3%
$7M
—
$294918
Jun '21
$35M
$13M
0.0%
29.5%
—
—
$484090
Valuation over time
How the market has priced BTMD against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 35.1× (Jan '24) to 2.2× (Jun '26).
The price-to-sales ratio has fallen from 1.1× (Mar '23) to 0.3× (Jun '26).
The dividend yield has fallen from 6.8% (Mar '23) to 2.9% (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is BTMD growing its revenue and profit?
Over the past 4 years, biote Corp.'s revenue has grown 8.4% per year, and net income grown 24.9% per year. These are computed facts, not advice.
How much debt does BTMD have?
As of FY2025, biote Corp. reported $103M of total debt against $24M of cash.
What is BTMD's profit margin?
In FY2025, gross margin was —, operating margin 18.5%, and net margin 14.1%.
What is BTMD's P/E ratio?
As of Jun '26, biote Corp. traded at a price-to-earnings ratio of about 2.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.